1. A pharmaceutical composition comprising a compound of Formula I and pharmaceutically acceptable salts of R, R, R, R, R, and R are independently selected from the group consisting of H, SOH, or POH, provided that at least two of R-R are selected from SOH or RON, and delivery agent. 2. The composition according to claim 1, characterized in that at least three of R-R are selected from SOH or POH. 3. The composition according to claim 1, characterized in that at least four of the R-R are selected from SOH or RON. The composition according to claim 1, characterized in that at least five of R1-R6 are selected from SOH or POH. The composition according to claim 1, characterized in that R-R are selected from SOH or POH. 6. A pharmaceutical composition containing a compound of formula I and its pharmaceutically acceptable R, R, R, R and R and R independently are independently selected from H, SOH, or POH, and R3 is independently selected from SOH or POH, and a delivery agent. A pharmaceutical composition containing a compound of formula I and its pharmaceutically acceptable R, R, R, and R moieties are independently selected from H, SOH, or POH, and R and R are independently selected from SOH or POH, and a delivery agent selected from the group consisting of a pharmaceutically acceptable natural or synthetic polymer. 8. A pharmaceutical composition containing (i) a compound of formula I and its pharmaceutically acceptable solids where R, R, and R are independently selected from H, SOH, or POH, and R, R and R are independently selected from SOH or POH, and (ii) a delivery agent. A pharmaceutical composition comprising (i) a compound of formula II and pharmaceutically acceptable salts thereof, wherein R, R, P, R and R are independently selected from the group consisting of H, SOH or POH, and (ii) a delivery agent. A composition comprising a compound of formula I wherein R-R are pharmaceutically acceptable salts thereof and a delivery agent selected from a hydrophilic polymer
